Difference between revisions of "DZI20-135-Case-11"
From MGH Learn Pathology
(Automatic edit to upgrade to new templates) |
(Added status template) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 11: | Line 11: | ||
|supportingInfo=Meningothelial tumor consistent with known atypical meningioma, viable and without evidence of progression to anaplastic meningioma (permanent dx: recurrent/residual atypical meningioma) | |supportingInfo=Meningothelial tumor consistent with known atypical meningioma, viable and without evidence of progression to anaplastic meningioma (permanent dx: recurrent/residual atypical meningioma) | ||
|reasonCode=72 yo M with multiply recurrent atypical meningioma (s/p multiple resections, radiation, brachytherapy, pembrolizumab, and Avastin) now with imaging concerning for progression | |reasonCode=72 yo M with multiply recurrent atypical meningioma (s/p multiple resections, radiation, brachytherapy, pembrolizumab, and Avastin) now with imaging concerning for progression | ||
| − | |subject= | + | |subject=MGH |
| − | |performer= | + | |performer=NS495 |
|sequence=11 | |sequence=11 | ||
| + | |access=public | ||
}} | }} | ||
{{Media | {{Media | ||
| Line 32: | Line 33: | ||
|identifier=DZI20-135-Case-11_2 | |identifier=DZI20-135-Case-11_2 | ||
|modality=mrxs | |modality=mrxs | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Abw33 | ||
| + | |authoredOn=2025-10-24T13:26:16.837557+00:00 | ||
}} | }} | ||
Latest revision as of 08:26, October 24, 2025
